Role of positron emission tomography in mediastinal lymphatic staging of non-small cell lung cancer

European Journal of Cardio-thoracic Surgery

Volumn 33, Issue 2, 2008, Pages 294-299

  Melek, Huseyin ^a   Gunluoglu, Mehmet Zeki ^a   Demir, Adalet ^a   Akin, Hasan ^a   Olcmen, Aysun ^a   Dincer, Seyyit Ibrahim ^a  

^a Research Hospital   (Turkey)

Author keywords

Lung cancer; Mediastinoscopy; PET; Staging

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER STAGING; CLINICAL EFFECTIVENESS; CONFIDENCE INTERVAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FALSE POSITIVE RESULT; FEMALE; HISTOPATHOLOGY; HUMAN; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDIASTINOSCOPE; MEDIASTINOSCOPY; MEDIASTINUM METASTASIS; PATIENT REFERRAL; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; THORACOTOMY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MEDIASTINOSCOPY; MIDDLE AGED; NEOPLASM STAGING; PATIENT SELECTION; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 38349075836     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2007.11.019     Document Type: Article

References (22)

1. Mountain C.F., and Dresler C.M. Regional lymph node classification for lung cancer staging. Chest 111 (1997) 1718-1723
2. Ronald B.P., LoCicero J., and Daly B.D.T. Lung cancer: surgical treatment of non-small cell lung cancer. In: Shields T.W., LoCicero J., Ronald B.P., and Rusch V.W. (Eds). General thoracic surgery. 6th ed. (2005), Lippincott Williams & Wilkins, Philadelphia 1548-1587 Chapter 106
3. Toloza E.M., Harpole L., and McCrory D. Noninvasive staging of non-small cell lung cancer: a review of the current evidence. Chest 123 (2003) 137S-146S
4. Detterbeck F.C., Falen S., Rivera M.P., Halle J.S., and Socinski M.A. Seeking a home for a PET, Part 2, defining the appropriate place for positron emission tomography. Imaging in the staging of patients with suspected lung cancer. Chest 125 (2004) 2300-2308
5. Pieterman R.M., van Putten J.W., Meuzelaar J.J., Mooyaart E.L., Vaalburg W., Koeter G.H., Fidler V., Pruim J., and Groen H.J. Preoperative staging of non-small cell lung cancer with positron-emission tomography. N Engl J Med 343 (2000) 254-261
6. Birim O., Kappetein A.P., Stijnen T., and Bogers A.J. Meta-analysis of positron emission tomographic and computed tomographic imaging in detecting mediastinal lymph node metastases in non-small cell lung cancer. Ann Thorac Surg 79 (2005) 375-382
7. Kernstine K.H., McLaughlin K.A., Menda Y., Rossi N.P., Kahn D.J., Bushnell D.L., Graham M.M., Brown C.K., and Madsen M.T. Can FDG-PET reduce the need for mediastinoscopy in potentially resectable non-small cell lung cancer?. Ann Thorac Surg 73 (2002) 394-402
8. Vansteenkiste J.F., Stroobants S.G., De Leyn P.R., Dupont P.J., Verschakelen J.A., Nackaerts K.L., and Mortelmans L.A. Mediastinal lymph node staging with FDG-PET scan in patients with potentially operable non-small cell lung cancer: a prospective analysis of 50 cases. Leuven Lung Cancer Group. Chest 112 (1997) 1480-1486
9. Newcombe R.G. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med 17 (1998) 857-872
10. De Leyn P., Lardinois D., Van Schil P.E., Rami-Porta R., Passlick B., Zielinski M., Waller D.A., Lerut T., and Weder W. ESTS guidelines for preoperative lymph node staging for non-small cell lung cancer. Eur J Cardiothorac Surg 32 (2007) 1-8
11. Ponn R.B. Invasive diagnostic procedures. In: Shields T.W., LoCicero J., Ronald B.P., and Rusch V.W. (Eds). General thoracic surgery. 6th ed. (2005), Lippincott Williams & Wilkins, Philadelphia 299-313 Chapter 17
12. Toloza E.M., Harpole L., Detterbeck F., and McCrory D.C. Invasive staging of non-small cell lung cancer: a review of the current evidence. Chest 123 (2003) 157S-166S
13. Bury T., Paulus P., Dowlati A., Corhay J.L., Weber T., Ghaye B., Schoffers J., Limet R., Albert A., Rigo P., and Radermecker M. Staging of the mediastinum: value of positron emission tomography imaging in non-small cell lung cancer. Eur Respir J 9 (1996) 2560-2564
14. Scott W.J., Gobar L.S., Terry J.D., Dewan N.A., and Sunderland J.J. Mediastinal lymph node staging of non-small-cell lung cancer: a prospective comparison of computed tomography and positron emission tomography. J Thorac Cardiovasc Surg 111 (1996) 642-648
15. Sasaki M., Ichiya Y., Kuwabara Y., Akashi Y., Yoshida T., Fukumura T., Murayama S., Ishida T., Sugio K., and Masuda K. The usefulness of FDG positron emission tomography for the detection of mediastinal lymph node metastases in patients with non-small cell lung cancer: a comparative study with X-ray computed tomography. Eur J Nucl Med 23 (1996) 741-747
16. Gonzalez-Stawinski G.V., Lemaire A., Merchant F., O'Halloran E., Coleman R.E., Harpole D.H., and D'Amico T.A. A comparative analysis of positron emission tomography and mediastinoscopy in staging non-small cell lung cancer. J Thorac Cardiovasc Surg 126 (2003) 1900-1905
17. Reed C.E., Harpole D.H., Posther K.E., Woolson S.L., Downey R.J., Meyers B.F., Heelan R.T., MacApinlac H.A., Jung S.H., Silvestri G.A., Siegel B.A., and Rusch V.W. Results of the American College of Surgeons Oncology Group Z0050 Trial: the utility of positron emission tomography in staging potentially operable non-small cell lung cancer. J Thorac Cardiovasc Surg 126 (2003) 1943-1951
18. Roberts P.F., Follette D.M., von Haag D., Park J.A., Valk P.E., Pounds T.R., and Hopkins D.M. Factors associated with false positive staging of lung cancer by positron emission tomography. Ann Thorac Surg 70 (2000) 1154-1159
19. Halpern B.S., Schiepers C., Weber W.A., Crawford T.L., Fueger B.J., Phelps M.E., and Czernin J. Presurgical staging of non-small cell lung cancer: positron emission tomography, integrated positron emission tomography/CT, and software image fusion. Chest 128 (2005) 2289-2297
20. Graeter T.P., Hellwig D., Hoffmann K., Ukena D., Kirsch C.M., and Schafers H.J. Mediastinal lymph node staging in suspected lung cancer: comparison of positron emission tomography with f-18-fluorodeoxyglucose and mediastinoscopy. Ann Thorac Surg 75 (2003) 231-236
21. de Langen A.J., Raijmakers P., Riphagen I., Paul M.A., and Hoekstra O.S. The size of mediastinal lymph nodes and its relation with metastatic involvement: a meta-analysis. Eur J Cardiothorac Surg 29 (2006) 26-29
22. Gould M.K., Kuschner W.G., Rydzak C.E., Maclean C.C., Demas A.N., Shigemitsu H., Chan J.K., and Owens D.K. Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small cell lung cancer: a meta-analysis. Ann Intern Med 139 (2003) 879-892